Ascent Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.6M Buy
18,846
+1,544
+9% +$1.58M 0.68% 30
2026
Q1
$15.9M Sell
17,302
-1,099
-6% -$1.11M 0.55% 40
2025
Q4
$19.8M Buy
18,401
+580
+3% +$555K 0.68% 29
2025
Q3
$13.6M Buy
17,821
+575
+3% +$428K 0.48% 44
2025
Q2
$13.4M Buy
17,246
+2,346
+16% +$1.82M 0.52% 46
2025
Q1
$12.3M Buy
14,900
+3,695
+33% +$3.07M 0.53% 45
2024
Q4
$8.65M Buy
11,205
+923
+9% +$764K 0.65% 31
2024
Q3
$9.11M Sell
10,282
-635
-6% -$571K 0.69% 30
2024
Q2
$9.88M Sell
10,917
-400
-4% -$320K 0.8% 23
2024
Q1
$8.8M Sell
11,317
-2,080
-16% -$1.48M 0.78% 21
2023
Q4
$9.88M Buy
13,397
+170
+1% +$99.2K 0.94% 19
2023
Q3
$7.82M Sell
13,227
-1,187
-8% -$612K 0.86% 21
2023
Q2
$7.52M Sell
14,414
-1,473
-9% -$618K 0.83% 21
2023
Q1
$5.46M Buy
15,887
+349
+2% +$118K 0.58% 31
2022
Q4
$5.68M Sell
15,538
-560
-3% -$199K 0.67% 22
2022
Q3
$5.83M Buy
16,098
+3,068
+24% +$972K 0.71% 21
2022
Q2
$4.3M Buy
13,030
+5,375
+70% +$1.61M 0.51% 40
2022
Q1
$2.19M Buy
7,655
+2,427
+46% +$625K 0.26% 137
2021
Q4
$1.27M Buy
+5,228
New +$1.33M 0.16% 194

Other funds holding LLY

Ascent Group's LLY Position: Q2 2026 in Review

Ascent Group increased its Eli Lilly (LLY) stake by 8.9% in Q2 2026, buying an estimated $1.58M and bringing the position to 18,846 shares worth $22.6M. The position accounts for 0.68% of the portfolio, ranked #30.

Ascent Group first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 4,600 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ascent Group held 18,846 shares of Eli Lilly worth $22.6M as of Q2 2026.
  • Ascent Group bought 1,544 Eli Lilly shares in Q2 2026, an estimated $1.58M.
  • Eli Lilly made up 0.68% of Ascent Group's portfolio in Q2 2026, its #30 holding.
  • Ascent Group first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 4,600 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.